Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Vertex Pharmaceuticals Pay Versus Performance by Year
Pay Versus Performance — Value of initial fixed $100 investment in Nasdaq Biotechnology Index peer TSR ($) ($)
Vertex Pharmaceuticals Pay Versus Performance: $125 in FY2025, up 33.4% from a year earlier.
Where the FY2025 figure comes from
“|| 2025 | $ 21,144,261 | $ 38,218,069 | $ 7,727,328 | $ 13,414,754 | $ 191.83 | $ 124.75 | $ 4.0 Billion | $ 11.97 Billion”
Source: Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗
Reported in DEF 14A Proxy Statements (Pay Versus Performance Table).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pay Versus Performance — Value of initial fixed $100 investment in Nasdaq Biotechnology Index peer TSR ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 125 | +33.4% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2024 | Dec 31, 2024 | 93.49 | -0.6% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2023 | Dec 31, 2023 | 94.03 | +4.6% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2022 | Dec 31, 2022 | 89.90 | -10.1% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2021 | Dec 31, 2021 | 100 | – | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Pay Versus Performance ($), annual FY2021–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nbi-tsr-100
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?